Long-term outcomes of a prospective single institution study with multiagent chemotherapy and stereotactic body radiation therapy in locally advanced or recurrent pancreatic adenocarcinoma.

Authors

null

Colin Hill

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD

Colin Hill , Lauren M. Rosati , Hao Wang , Hua-Ling Tsai , Shuchi Sehgal , Vincent Bernard , John L. Cameron , Jin He , Amy Hacker-Prietz , Daniel A. Laheru , Lei Zheng , Richard A. Burkhart , Ana De Jesus-Acosta , Dung T. Le , Matthew John Weiss , Christopher Lee Wolfgang , Amol Narang , Joseph M. Herman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Pancreatic Cancer

Track

Pancreatic Cancer

Sub Track

Other

Clinical Trial Registration Number

NCT01781728

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 440)

DOI

10.1200/JCO.2021.39.3_suppl.440

Abstract #

440

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Amit Jethanandani

Poster

2022 ASCO Annual Meeting

Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.

Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.

First Author: Katherine E Poruk